DENTSPLY SIRONA

Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Technologies and Equipment and Consumables. The Technologies and Equipment segments comprises dental technology, equipment and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers and consumable medical device products. The Consumables segment offers preventive, restorative, instruments, endodontic and orthodontic dental products. The company was founded in 1899 and is headquartered in Charlotte, NC.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Dentsply Sirona (XRAY) exceeds Q4 expectations, focuses on innovation

Dentsply Sirona (XRAY) reported strong financial performance in Q4 2022, with a strategic focus on digitalization and innovation. Despite challenges in organic sales and supply chain constraints, the company aims for margin improvement and growth opportunities through investments and pricing strategies. Restructuring efforts and acquisitions are set to drive profitability and market share gains.

Dentsply Sirona reports robust Q1 growth, eyes digital innovation

Dentsply Sirona's strong Q1 performance driven by Consumables and Aligners segments.
Challenges include mixed regional performance and cautious outlook on equipment demand.
Opportunities lie in digitalization, DSO partnerships, and growth in China and EPS targets.
Overall, a positive outlook with strategic focus on innovation and customer experience.

Dentsply Sirona exceeds Q2 expectations, eyes growth amid challenges

Dentsply Sirona reported strong financial performance in Q2 2023, exceeding expectations and raising full-year outlook across key financial metrics.
The company's strategic focus on growth, profitability, and digitalization, coupled with investments in key regions and product innovation, positions it for sustained success.
While facing challenges in certain markets and operational areas, Dentsply Sirona remains optimistic about opportunities for growth, innovation, and value creation in the dental industry.
Overall, Dentsply Sirona's performance highlights operational strengths, market positioning, and a forward-looking approach to driving shareholder value and market expansion.

DENTSPLY SIRONA reports mixed Q3 results, focuses on innovation and growth

DENTSPLY SIRONA's Q3 performance showed mixed results with challenges in certain markets but strength in key segments like CAD/CAM and Aligners.
The company is focused on driving value through innovation, maintaining a commitment to long-term plans, and navigating external challenges with confidence.
Despite headwinds, DENTSPLY SIRONA remains within guidance range for the year, with a strategic focus on volume growth and market expansion opportunities.

DENTSPLY SIRONA anticipates double-digit EPS growth in 2024

DENTSPLY SIRONA's Q4 2023 performance showed growth in key segments, with strategic initiatives set for 2024 as an inflection year for double-digit EPS growth.
The company is focusing on innovation, SKU optimization, and operational efficiency to drive profitability and revenue growth.
Challenges lie in certain segments and the need for organic growth normalization by 2025, but opportunities exist in new product launches and margin expansion.
Overall, DENTSPLY SIRONA is poised for accelerated profitable growth, with 2024 expected to be a pivotal year for improved performance.

DENTSPLY SIRONA reports mixed Q1 performance amidst innovation focus

DENTSPLY SIRONA navigated challenges in Q1 with a focus on innovation, sustainability, and strategic updates. While facing headwinds in certain segments and markets, the company aims to capitalize on growth opportunities through product launches and strategic initiatives.

DENTSPLY Sirona navigates revenue decline with strategic restructuring plans

DENTSPLY Sirona's Q2 performance reflects revenue decline and margin contraction, prompting strategic restructuring and focus on customer-centric initiatives. While facing challenges from macroeconomic factors and restructuring impacts, the company aims to leverage opportunities in shareholder returns and market dynamics to drive growth and operational efficiency.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment is engaged in designing, manufacturing, and selling dental technology and equipment products. The Essential Dental Solutions segment designs, manufactures, and sells value-added endodontic, restorative, and preventive consumable products. The Orthodontic and Implant Solutions segment designs, manufactures, and sells various digital implant systems and dental implant products. The Wellspect Healthcare segment designs, manufactures, and sells continence care solutions for management of both urinary and bowel dysfunction dental products. The company was founded in 1899 and is headquartered in Charlotte, NC.

Retractable Technologies

Their products are never going out of style, and their valuations are attractive.

2 Evergreen Value Stocks You Could Buy and Hold Forever

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- #AirDisinfection--Announcement of new CFO for WellAir.

WellAir Appoints Kari Dixon as Chief Financial Officer

Dentsply Sirona Inc. (XRAY) CEO Don Casey on Q2 2021 Results - Earnings Call Transcript

DENTSPLY SIRONA's (XRAY) second-quarter results benefit from strong segmental performance.

DENTSPLY SIRONA (XRAY) Q2 Earnings & Revenues Beat Estimates

Dentsply (XRAY) delivered earnings and revenue surprises of 9.23% and 6.95%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Dentsply International (XRAY) Beats Q2 Earnings and Revenue Estimates

CHARLOTTE, N.C., Aug. 05, 2021 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its financial results for the second quarter of 2021.

Dentsply Sirona Reports Second Quarter 2021 Results

DENTSPLY SIRONA's (XRAY) second-quarter results are likely to reflect strong segmental performance.

DENTSPLY SIRONA (XRAY) to Post Q2 Earnings: What's in Store?

Dentsply (XRAY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Dentsply International (XRAY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

UnitedHealth Group

UnitedHealth Group, Ryman Healthcare, and Dentsply Sirona all had double-digit revenue increases recently. Are any of them worth buying?

Do Big Dividend Increases Make These 3 Medical Stocks Worth Buying?

Align Technology

Henry Schein

Patterson Companies

Dental stocks like Henry Schein (HSIC), Align Technology (ALGN), Straumann Holding (SAUHF) and DENTSPLY SIRONA (XRAY) are expected to continue their run over the next few months.

Dental Space Gains Momentum in 2021: 4 Stocks to Invest in

CHARLOTTE, N.C., July 06, 2021 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), announced today that the Company will be hosting an investor conference call and live webcast on Thursday, August 5, 2021 at 8:30 am ET to review its financial results. A presentation related to the call will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com.

DENTSPLY SIRONA to Host Second Quarter 2021 Conference Call on August 5th

Medtronic

Portland General Electric

All stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List.

3 Upcoming Dividend Increases Including Medtronic

DENTSPLY SIRONA (XRAY) to fortifies its presence further in the clear aligner market with the acquisition of Propel Orthodontics.

DENTSPLY SIRONA (XRAY) Boosts Clear Aligner Foothold With Buyout

Dentsply Sirona has seen a solid start to 2021 and has gotten active on the deal front again.

Dentsply Sirona - Getting Prettier

Dentsply (XRAY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

All You Need to Know About Dentsply (XRAY) Rating Upgrade to Buy

CHARLOTTE, N.C., June 04, 2021 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), today announced that it has acquired substantially all of the assets of Propel Orthodontics in an all-cash deal for $131 million. The assets acquired include the VPro device and the Fastrack Mobile App. Propel Orthodontics is a leading innovator, manufacturer, and worldwide seller of orthodontic devices. Propel Orthodontics offers in-office and at-home orthodontic solutions to dentists and their patients. The acquisition is an important step for Dentsply Sirona to further strengthen its position in the fast-growing clear aligner market. The acquired product lines perfectly complement the Byte® and SureSmile® businesses.

DENTSPLY SIRONA Acquires the Assets of Propel Orthodontics, a Leading Innovator in Orthodontic Devices

CHARLOTTE, N.C., May 27, 2021 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), announced that its Board of Directors approved a 10% increase in the company's quarterly dividend rate, from the previous rate of $0.10 per share of common stock to $0.11 per share. The dividend is payable on July 9, 2021 to holders of record as of June 25, 2021.

DENTSPLY SIRONA Increases Quarterly Cash Dividend By 10%

CHARLOTTE, N.C., May 24, 2021 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), The Dental Solutions Company, today announced the Company will present at four investor conferences in June.

Dentsply Sirona to Present at Four Upcoming Virtual Investor Conferences

Dentsply Sirona Inc. (XRAY) CEO Don Casey on Q1 2021 Results - Earnings Call Transcript

Bruker

ON Semiconductor

Trane Technologies plc

Under Armour

Volkswagen AG

Large-caps bring stability to your portfolio because they don't react as aggressively to news and other events.

Large-Cap Stocks Bring Stability to Your Portfolio

Dentsply (XRAY) delivered earnings and revenue surprises of 30.91% and 10.51%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Dentsply International (XRAY) Surpasses Q1 Earnings and Revenue Estimates

CHARLOTTE, N.C., May 06, 2021 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY), The Dental Solutions Company, today announced its financial results for the first quarter of 2021.

Dentsply Sirona Reports First Quarter 2021 Results

Inogen

Owens & Minor

Rebound in base sales make us optimistic about OMI, INGN, XRAY and CNTG's results this time around.

4 Medical Products Stocks Set to Beat This Earnings Season

XRAY vs. ALGN: Which Stock Is the Better Value Option?

News for DENTSPLY SIRONA Stock (XRAY)